KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Construction in Progress (2016 - 2024)

Eli Lilly (LLY) has disclosed Construction in Progress for 13 consecutive years, with $8.2 billion as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Construction in Progress rose 62.17% year-over-year to $8.2 billion, compared with a TTM value of $8.2 billion through Dec 2024, up 62.17%, and an annual FY2024 reading of $8.2 billion, up 62.17% over the prior year.
  • Construction in Progress was $8.2 billion for Q4 2024 at Eli Lilly, up from $5.1 billion in the prior quarter.
  • Across five years, Construction in Progress topped out at $8.2 billion in Q4 2024 and bottomed at $2.1 billion in Q4 2020.
  • Average Construction in Progress over 5 years is $4.1 billion, with a median of $2.8 billion recorded in 2022.
  • The sharpest move saw Construction in Progress grew 1.82% in 2021, then skyrocketed 81.67% in 2023.
  • Year by year, Construction in Progress stood at $2.1 billion in 2020, then grew by 1.82% to $2.2 billion in 2021, then grew by 28.51% to $2.8 billion in 2022, then soared by 81.67% to $5.1 billion in 2023, then skyrocketed by 62.17% to $8.2 billion in 2024.
  • Business Quant data shows Construction in Progress for LLY at $8.2 billion in Q4 2024, $5.1 billion in Q4 2023, and $2.8 billion in Q4 2022.